Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Zostavax Market Report 2025

Zostavax Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Formulation (Recombinant Vaccine (Shingrix), Live Attenuated Vaccine (Zostavax)), By Indication (Shingles Prevention, Post-Herpetic Neuralgia), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies)

Zostavax Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Zostavax Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Zostavax Market Definition

Zostavax is a vaccine developed to prevent shingles, a painful rash caused by the reactivation of the varicella-zoster virus, which also causes chickenpox. It is primarily recommended for adults aged 50 and older to reduce the risk of developing shingles and its associated complications, such as postherpetic neuralgia.

The main types of zostavax formulations are recombinant vaccine (shingrix) and live attenuated vaccine (zostavax). A recombinant vaccine is made by using genetic engineering to produce an antigen that triggers an immune response without using a live virus. It is used for shingles prevention and post-herpetic neuralgia and is distributed through hospitals and retail pharmacies.

Zostavax Market Segmentation

The zostavax market covered in this report is segmented –

1) By Formulation: Recombinant Vaccine (Shingrix); Live Attenuated Vaccine (Zostavax)

2) By Indication: Shingles Prevention; Post-Herpetic Neuralgia

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies

Zostavax Market Size and growth rate 2025 to 2029: Graph

Zostavax Market Size 2025 And Growth Rate

The zostavax market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to growth in preventive healthcare, an increase in vaccine accessibility, growth in insurance coverage, a rise in awareness about shingles and its complications, and the inclusion of shingles vaccines in national immunization programs.

Zostavax Market Growth Forecast

The zostavax size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to a surge in new shingles vaccine approvals by regulatory authorities, increasing cost-effectiveness of vaccines over treatments, a rise in new vaccine approvals, high adoption of shingrix among the developed countries, and increasing prevalence of chronic diseases. Major trends in the forecast period include a shift toward advanced products, emerging initiatives from companies in research and development of vaccines, government initiatives and public health campaigns, expanding outreach programs in rural areas to increase awareness and accessibility of the shingles vaccine, and technological advancement.

Book your 30 minutes free consultation with our research experts

Contact Us

Zostavax Market Driver: Impact Of Healthcare Infrastructure Expansion On Vaccine Accessibility And Uptake

The expansion of healthcare infrastructure in developing countries is expected to propel the growth of the zostavax market going forward. Healthcare infrastructure refers to the integrated network of facilities, equipment, personnel, and systems required to deliver effective and efficient healthcare services to a population. The expansion of healthcare infrastructure in developing countries is primarily due to growing investments in healthcare facilities and improved access to medical services. Healthcare infrastructure supports zostavax by providing the necessary facilities, resources, and delivery systems to administer the vaccine to the target population, particularly in clinics, hospitals, and pharmacies. For instance, in May 2023, according to the Department of Health and Social Care, a UK-based government department, the UK government has confirmed that the New Hospital Programme receives over $25.33 billion (£20 billion) in investment, aimed at fulfilling the commitment to build 40 new hospitals in England by 2030. In addition to replacing five RAAC hospitals, the program includes three mental health hospitals as part of a broader effort to eliminate dormitory accommodation in mental health facilities and promote equality between physical and mental health care. Two hospitals have already been completed, five are under construction, and over 20 are set to be underway or completed by the end of next year. Therefore, the expansion of healthcare infrastructure in developing countries is driving the growth of the zostavax market.

Zostavax Market Driver: Impact Of Growing Geriatric Population On Vaccine Demand

The surge in the geriatric population is expected to propel the growth of the zostavax market going forward. The geriatric population refers to individuals who are typically aged 65 and older, often requiring specialized medical care due to age-related health issues. The geriatric population is increasing globally due to advancements in healthcare, improved living standards, and better disease management, which have contributed to longer life expectancies. Zostavax is required for the geriatric population because aging weakens the immune system, increasing the risk of developing shingles and its complications, making vaccination essential for prevention. For instance, in October 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, one in six people worldwide will be 60 years or older by 2030, with the population in this age group rising from 1 billion in 2020 to 1.4 billion. By 2050, the global population of individuals aged 60 and above is expected to double, reaching 2.1 billion. Additionally, the number of people aged 80 or older is projected to triple between 2020 and 2050, reaching 426 million. Therefore, the surge in the geriatric population is driving the growth of the zostavax market.

Zostavax Market Driver: Rising Insurance Coverage Driving Increased Vaccine Accessibility And Adoption

The growth in insurance coverage is expected to propel the growth of the zostavax market going forward. Insurance coverage refers to the protection provided by an insurance policy, where the insurer agrees to pay for certain financial losses or medical expenses incurred by the insured, based on the terms and conditions of the policy. Insurance coverage is rising due to increasing awareness of health risks, rising medical costs, and a growing demand for financial protection against unforeseen events and chronic conditions. Zostavax helps insurance coverage by providing a preventative vaccine for shingles, which reduces the risk of costly treatments and long-term healthcare expenses associated with the disease, thereby encouraging insurers to cover its cost as part of proactive health management for eligible individuals, particularly those aged 50 and above. For instance, in December 2023, according to the U.S. Centers for Medicare & Medicaid Services, a US-based federal agency, the proportion of the population with insurance reached a historic high of 92% in 2022. Enrollment in Medicaid increased by 6.1 million people, while enrollment in private health insurance increased by 2.9 million people. Therefore, the growth in insurance coverage is driving the growth of the zostavax market.

Global Zostavax Market Major Players

Major companies operating in the zostavax market are Merck & Co. Inc.

Regional Analysis For The Global Zostavax Market

North America was the largest region in the zostavax market in 2024. The regions covered in the zostavax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the zostavax market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Zostavax Market?

The zostavax market consists of sales of flu vaccines, pneumococcal vaccines hepatitis vaccines and meningitis vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Zostavax Industry?

The zostavax market research report is one of a series of new reports from The Business Research Company that provides zostavax market statistics, including zostavax industry global market size, regional shares, competitors with a zostavax market share, detailed zostavax market segments, market trends and opportunities, and any further data you may need to thrive in the zostavax industry. This zostavax market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Zostavax Market Characteristics

    3. Zostavax Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Zostavax Market Trends And Strategies

    5. Zostavax Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Zostavax Growth Analysis And Strategic Analysis Framework

    6.1. Global Zostavax PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Zostavax Market Growth Rate Analysis

    6.4. Global Zostavax Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Zostavax Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Zostavax Total Addressable Market (TAM)

    7. Global Zostavax Pricing Analysis & Forecasts

    8. Zostavax Market Segmentation

    8.1. Global Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Recombinant Vaccine (Shingrix)

    Live Attenuated Vaccine (Zostavax)

    8.2. Global Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Shingles Prevention

    Post-Herpetic Neuralgia

    8.3. Global Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospital Pharmacies

    Retail Pharmacies

    9. Global Zostavax Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Zostavax Market Regional And Country Analysis

    10.1. Global Zostavax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Zostavax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Zostavax Market

    11.1. Asia-Pacific Zostavax Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Zostavax Market

    12.1. China Zostavax Market Overview

    12.2. China Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Zostavax Market

    13.1. India Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Zostavax Market

    14.1. Japan Zostavax Market Overview

    14.2. Japan Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Zostavax Market

    15.1. Australia Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Zostavax Market

    16.1. South Korea Zostavax Market Overview

    16.2. South Korea Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Zostavax Market

    17.1. Western Europe Zostavax Market Overview

    17.2. Western Europe Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Zostavax Market

    18.1. UK Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Zostavax Market

    19.1. Germany Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Zostavax Market

    20.1. France Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Zostavax Market

    21.1. Eastern Europe Zostavax Market Overview

    21.2. Eastern Europe Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Zostavax Market

    22.1. North America Zostavax Market Overview

    22.2. North America Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Zostavax Market

    23.1. USA Zostavax Market Overview

    23.2. USA Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Zostavax Market

    24.1. Canada Zostavax Market Overview

    24.2. Canada Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Zostavax Market

    25.1. South America Zostavax Market Overview

    25.2. South America Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Zostavax Market

    26.1. Middle East Zostavax Market Overview

    26.2. Middle East Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Zostavax Market

    27.1. Africa Zostavax Market Overview

    27.2. Africa Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Zostavax Market Competitive Landscape And Company Profiles

    28.1. Zostavax Market Competitive Landscape

    28.2. Zostavax Market Company Profiles

    28.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Zostavax Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Zostavax Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Zostavax Market

    32. Recent Developments In The Zostavax Market

    33. Zostavax Market High Potential Countries, Segments and Strategies

    33.1 Zostavax Market In 2029 - Countries Offering Most New Opportunities

    33.2 Zostavax Market In 2029 - Segments Offering Most New Opportunities

    33.3 Zostavax Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Zostavax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Zostavax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Merck & Co. Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Zostavax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Zostavax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Zostavax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Zostavax Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Zostavax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Merck & Co. Inc. Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

Global Cancer Immunotherapy Market Overview And Prospects – Includes Cancer Immunotherapy Market Share

Read More

How Will The Biosimilar Interleukins Market Grow In 2022?

Read More

Latest Cancer Clinical Decision Tools Market Growth Study 2022-2026 By The Business Research Company

Read More

Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the pegfilgrastim biosimilars market market research report 2022 with industry size, share, segments and market growth

Read More

Factoring Market 2023 – By Type (Recourse, Non-Recourse), By Organization Size (Small And Medium Enterprises, Large Enterprises), By Category (International, Domestic), By Application (Transportation, Healthcare, Construction, Manufacturing, Other Applications), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Automotive Performance Tuning And Engine Remapping Services Global Market Report 2025 – By Service (Engine Tuning, Suspension Tuning, Transmission Tuning, Interior Tuning, Exterior Tunning), By Fuel Type (Petrol, Diesel), By Sales Channel (Original equipment manufacturer (OEM), Aftermarket), By Application (Passenger Cars, Light Commercial Vehicles (LCV), Motorcycle, Heavy Commercial Vehicles, Off-Highway Vehicles) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiac Safety Services Global Market Report 2025 – By Services (ECG Or Holter Measurements, Blood Pressure Measurements, In Vitro Cardiac Safety Assessment Services, Cardiovascular Imaging, Real-Time Telemetry Monitoring, Central Over-Read Of ECGS, Non-Invasive Cardiac Imaging, Physiologic Stress Testing, Thorough QT Studies, Other services ), By Phase (Phase 1, Phase 2, Phase 3), By End User (Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institute) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Plant-Based Vaccines Global Market Report 2025 – By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types), By Source (Tobacco Plant, Maize, Potato, Other Sources), By Application (Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Preclinical Assets Global Market Report 2025 – By Service (Bioanalysis And DMPK (Drug Metabolism and Pharmacokinetic) studies, Toxicology Testing, Compound Management, Safety Pharmacology, Other Services), By Model Type (Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model), By End User (Biopharmaceutical Companies, Government Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Zostavax market?

Zostavax is a vaccine developed to prevent shingles, a painful rash caused by the reactivation of the varicella-zoster virus, which also causes chickenpox. It is primarily recommended for adults aged 50 and older to reduce the risk of developing shingles and its associated complications, such as postherpetic neuralgia. For further insights on the Zostavax market, request a sample here

How will the Zostavax market drivers and restraints affect the market dynamics? What forces will shape the Zostavax industry going forward?

The Zostavax market major growth driver - Impact Of Healthcare Infrastructure Expansion On Vaccine Accessibility And Uptake. For further insights on the Zostavax market, request a sample here

What is the forecast market size or the forecast market value of the Zostavax market?

The Zostavax market size has grown strongly in recent years. The zostavax market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to growth in preventive healthcare, an increase in vaccine accessibility, growth in insurance coverage, a rise in awareness about shingles and its complications, and the inclusion of shingles vaccines in national immunization programs. The zostavax size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to a surge in new shingles vaccine approvals by regulatory authorities, increasing cost-effectiveness of vaccines over treatments, a rise in new vaccine approvals, high adoption of shingrix among the developed countries, and increasing prevalence of chronic diseases. Major trends in the forecast period include a shift toward advanced products, emerging initiatives from companies in research and development of vaccines, government initiatives and public health campaigns, expanding outreach programs in rural areas to increase awareness and accessibility of the shingles vaccine, and technological advancement. For further insights on the Zostavax market, request a sample here

How is the Zostavax market segmented?

The zostavax market covered in this report is segmented –
1) By Formulation: Recombinant Vaccine (Shingrix); Live Attenuated Vaccine (Zostavax)
2) By Indication: Shingles Prevention; Post-Herpetic Neuralgia
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies For further insights on the Zostavax market, request a sample here

Which region has the largest share of the Zostavax market? What are the other regions covered in the report?

North America was the largest region in the zostavax market in 2024. The regions covered in the zostavax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Zostavax market, request a sample here.

Who are the major players in the Zostavax market?

Major companies operating in the zostavax market are Merck & Co. Inc. . For further insights on the Zostavax market, request a sample here.

What are the key trends in the Zostavax market?

Major trends in the Zostavax market include . For further insights on the Zostavax market, request a sample here.

What are the major opportunities in the Zostavax market? What are the strategies for the Zostavax market?

For detailed insights on the major opportunities and strategies in the Zostavax market, request a sample here.

How does the Zostavax market relate to the overall economy and other similar markets?

For detailed insights on Zostavax's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Zostavax industry?

For detailed insights on the mergers and acquisitions in the Zostavax industry, request a sample here.

What are the key dynamics influencing the Zostavax market growth? SWOT analysis of the Zostavax market.

For detailed insights on the key dynamics influencing the Zostavax market growth and SWOT analysis of the Zostavax industry, request a sample here.